Last edition
News about Market
MiNK Therapeutics collaborates with C-Further consortium to develop PRAME-targeted TCR-engineered iNKT cell therapy for paediatric cancers, aiming to deliver innovative immunotherapy options for children with limited treatment alternatives.
Market | 12/03/2026 | By News Bureau | 148
Immunic Secures European Patent for Vidofludimus Calcium, Strengthening Long-Term Market Exclusivity
Immunic receives European patent protection for Vidofludimus Calcium dosing regimens, reinforcing intellectual property coverage and potentially extending exclusivity for the multiple sclerosis therapy in Europe until 2043.
Market | 12/03/2026 | By News Bureau | 149
Serum Institute and Bavarian Nordic Expand Partnership for Chikungunya Vaccine Manufacturing
Bavarian Nordic and Serum Institute of India have expanded their strategic partnership through a chikungunya vaccine manufacturing agreement, enabling full technology transfer and supporting future supply to low- and middle-income countries while opening opportunities for further co-development.
Market | 11/03/2026 | By News Bureau | 237
API Exports Reach INR 41,500 Crore, Overtake Imports In FY25
India’s exports of active pharmaceutical ingredients (APIs) exceeded imports in the financial year 2024–25, reflecting the country’s strengthening capabilities in bulk drug manufacturing.
Market | 11/03/2026 | By Darshana | 504
Medtronic Signs USD 550 Million Deal To Buy Scientia Vascular
Medtronic plc has entered into a definitive agreement to acquire Scientia Vascular for USD 550 million, as the medical technology giant looks to strengthen its neurovascular portfolio and expand capabilities in stroke treatment.
Market | 11/03/2026 | By Darshana | 174
Agilent to Acquire Biocare Medical
Agilent Technologies has agreed to acquire Biocare Medical, expanding its pathology portfolio with complementary antibodies, reagents and instruments. The acquisition is expected to strengthen Agilent’s revenue growth, margin profile and non-instrument revenue mix from the first year.
Market | 11/03/2026 | By News Bureau | 169
Jiahui International Cancer Centre in Shanghai treats a US patient with advanced Non?Small Cell Lung Cancer using Ivonescimab, an experimental immunotherapy currently available only in China.
Market | 09/03/2026 | By News Bureau | 188
Hopewell Therapeutics and Foxcroft Therapeutics partner to advance cancer vaccines using tissue-targeting lipid nanoparticles, enabling improved delivery systems with large-animal trials planned later in 2026.
Market | 09/03/2026 | By News Bureau | 334
Alembic Pharmaceuticals reports first prescription sale of Pivya in the US, marking its entry into the branded pharmaceutical segment with a first-line oral antibiotic for uncomplicated urinary tract infections in women.
Market | 07/03/2026 | By News Bureau | 205
Women's Leadership in UK Biotech Stagnates Despite Strong Funding Wins by Female CEOs: BIA Report
A new BioIndustry Association report finds women’s representation in UK biotech leadership largely unchanged, with female CEOs at 18.7 percent, while funding gains remain concentrated among a few standout companies.
Market | 06/03/2026 | By News Bureau | 196
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy